FNCH
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
$40
About FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Details
Daily high
$13.52
Daily low
$13.30
Price at open
$13.40
52 Week High
$16.10
52 Week Low
$10.15
Market cap
21.5M
Dividend yield
0.00%
Volume
5,280
Avg. volume
7,813
P/E ratio
-1.52
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. News
Details
Daily high
$13.52
Daily low
$13.30
Price at open
$13.40
52 Week High
$16.10
52 Week Low
$10.15
Market cap
21.5M
Dividend yield
0.00%
Volume
5,280
Avg. volume
7,813
P/E ratio
-1.52